Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of scleroderma (systemic sclerosis)

E C LeRoy

    The Journal of Investigative Dermatology
    |July 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Scleroderma research suggests blood vessels and endothelial cells are key targets. Early detection of microvascular issues and understanding immune responses may lead to new scleroderma therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites.

    The Journal of steroid biochemistry and molecular biology·2010
    Same author

    The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts.

    Clinical and experimental rheumatology·2004
    Same author

    A profibrotic polymorphism (of TGFbeta1) in systemic sclerosis.

    Annals of the rheumatic diseases·2002
    Same author

    Anti-fibrillin-1 autoantibodies in systemic sclerosis are GM and KM allotype-restricted.

    Experimental and clinical immunogenetics·2001
    Same author

    MCMV induces neointima in IFN-gammaR-/- mice: intimal cell apoptosis and persistent proliferation of myofibroblasts.

    BMC musculoskeletal disorders·2001
    Same author

    Criteria for the classification of early systemic sclerosis.

    The Journal of rheumatology·2001
    Same journal

    Residual CSB activity explains mild UV-sensitive syndrome phenotype caused by CSB mutations.

    The Journal of investigative dermatology·2026
    Same journal

    Charting a new melanoma risk factor: Satellite Naevus Prevalence in High-Risk and Population-Based Cohorts.

    The Journal of investigative dermatology·2026
    Same journal

    Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris.

    The Journal of investigative dermatology·2026
    Same journal

    Merkel cells attenuate autoantigen-specific T cell driven skin inflammation in mice associated with reduced neutrophil recruitment.

    The Journal of investigative dermatology·2026
    Same journal

    The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.

    The Journal of investigative dermatology·2026
    Same journal

    Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled Trial.

    The Journal of investigative dermatology·2026
    See all related articles

    Area of Science:

    • Vascular biology
    • Immunology
    • Rheumatology

    Background:

    • Scleroderma (systemic sclerosis) research increasingly focuses on vascular pathology.
    • The vascular hypothesis posits blood vessels and endothelial cells as primary targets in scleroderma.

    Purpose of the Study:

    • To explore the vascular hypothesis in scleroderma.
    • To identify potential early diagnostic markers and therapeutic targets related to vascular injury.

    Main Methods:

    • Review of observations supporting the vascular hypothesis.
    • Discussion of immune events and potential autoantigens (e.g., type IV collagen).
    • Emphasis on quantifying endothelial injury for disease monitoring.

    Main Results:

    Related Experiment Videos

    • Microvascular abnormalities may aid early scleroderma detection.
    • A serum protease cytotoxic to endothelial cells has been identified.
    • Serum mitogenic activity for fibroblasts is observed in scleroderma patients.

    Conclusions:

    • The vascular hypothesis provides a framework for understanding scleroderma.
    • Further research into immunity against basement membrane collagen is warranted.
    • Quantifying endothelial injury is crucial for assessing disease activity and treatment efficacy.